QUANTUM DASH DEVICES
    311.
    发明专利

    公开(公告)号:CA2424468C

    公开(公告)日:2008-04-01

    申请号:CA2424468

    申请日:2001-09-21

    Applicant: STC UNM

    Abstract: Quantum dot active region structures are disclosed. In a preferred embodiment, the distribution in dot size and the sequence of optical transition energy values associated with the quantum confined states of the dots are selected to facilitate forming a continuous optical gain spectrum over an extended wavelength range. In one embodiment, the quantum dots are self-assembled quantum dots with a length-to-width ratio of at least three along the growth plane. In one embodiment, the quantum dots are formed in quantum wells for improved carrier confinement. In other embodiments, the quantum dots are used as the active region in laser devices, including tunable lasers and monolithic multi-wavelength laser arrays.

    QUANTUM DOT LASERS
    313.
    发明专利

    公开(公告)号:CA2423782A1

    公开(公告)日:2002-07-25

    申请号:CA2423782

    申请日:2001-10-05

    Applicant: STC UNM

    Abstract: A quantum dot active region is disclosed in which quantum dot layers are formed using a self-assembled growth technique. In one embodiment, growth parameters are selected to control the dot density and dot size distribution to achieve desired optical gain spectrum characteristics. In one embodiment, the distribution in dot size and the sequence of optical transition energy values associated with the quantum confined states of the dots are selected to facilitate forming a continuous optical gain spectrum over an extended wavelength range. In another embodiment, the optical gain is selected to increase the saturated ground state gain for wavelengths of 1260 nanometers and greater. In other embodiments, the quantum dots are used as the active region in laser devices, including tunable lasers and monolithic multi- wavelength laser arrays.

    STEP-DERIVED PEPTIDE FOR BRAIN INJURY TREATMENT

    公开(公告)号:CA2811086C

    公开(公告)日:2020-07-21

    申请号:CA2811086

    申请日:2011-09-15

    Applicant: STC UNM

    Inventor: PAUL SUROJIT

    Abstract: A novel peptide sequence that is a modified derivative of a neuron-specific tyrosine phosphatase is shown and described. Specifically, the novel peptide sequence is a modified derivative of striatal-enriched tyrosine phosphatase (STEP). The peptide sequence has been modified so as to be able to ameliorate and treat brain injury resulting from excessive glutamate release and / or oxidative stress. Examples of the types of brain injury which the presently disclosed peptide sequence is useful for treating includes acute brain injury resulting from stroke or traumatic brain injury and chronic disorders such as Huntington's chorea and schizophrenia. Furthermore, the presently described peptide sequence may further be useful in the treatment and amelioration of disorders associated with fear memory such as post-traumatic stress disorder.

    A PRIVACY-PRESERVING, MUTUAL PUF-BASED AUTHENTICATION PROTOCOL

    公开(公告)号:CA3011279A1

    公开(公告)日:2017-07-20

    申请号:CA3011279

    申请日:2017-01-11

    Applicant: STC UNM

    Abstract: An authentication protocol using a Hardware-Embedded Delay PUF ("HELP"), which derives randomness from within-die path delay variations that occur along the paths within a hardware implementation of a cryptographic primitive, for example, the Advanced Encryption Standard ("AES") algorithm or Secure Hash Algorithm 3 ("SHA-3"). The digitized timing values which represent the path delays are stored in a database on a secure server (verifier) as an alternative to storing PUF response bitstrings thereby enabling the development of an efficient authentication protocol that provides both privacy and mutual authentication.

    microencapsulação como uma estratégia para implementação e proteção ambiental de um método paratransgênico para o controle de doenças transportadas por vetor

    公开(公告)号:BR112014014316A8

    公开(公告)日:2017-06-13

    申请号:BR112014014316

    申请日:2012-10-31

    Applicant: STC UNM

    Abstract: 1/1 resumo “microencapsulação como uma estratégia para implementação e proteção ambiental de um método paratransgênico para o controle de doenças transportadas por vetor” novos pesticidas com base em partícula formados a partir de agentes pesticidas encapsulados em um ou mais revestimentos em que o revestimento realça a capacidade do agente pesticida para controlar uma população de praga, e métodos para fabricar os mesmos. em várias formas de realização o agente pesticida pode ser um biopesticida e o revestimento pode comunicar estabilidade, proteção da radiação uv e/ou outras condições ambientais, realçam a atratividade do pesticida para a praga, e/ou serve para separar dois pesticidas diferentes, biologicamente incompatíveis dentro de uma mistura.

Patent Agency Ranking